If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBOCH.L Regulatory News (BOCH)

  • There is currently no data for BOCH

Total Voting Rights

2 Sep 2024 07:27

RNS Number : 4887C
Bank of Cyprus Holdings PLC
02 September 2024
 

 

 

Announcement

 

Bank of Cyprus Holdings Public Limited Company - Total voting rights and Capital and Progress on Share Buyback Programme

 

 

Nicosia, 2 September 2024

 

 

 

Bank of Cyprus Holdings Public Limited Company (the 'Company') announces that, as of 31 August 2024, the total issued share capital of the Company was 443,894,907 ordinary shares of nominal value €0.10 each, with each ordinary share carrying one vote.

 

The above figure 443,894,907 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Irish Transparency (Directive 2004/109/EC) Regulations 2007 (as amended), the Irish Central Bank (Investment Market Conduct) Rules 2019 and the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

In line with the purpose of the buyback programme, announced on 19 April 2024 (the 'Programme'), to reduce the share capital of the Company, the total number of shares repurchased under this programme as at 31 August 2024 is 2,425,620 ordinary shares (of which 2,305,026 ordinary shares have been cancelled as at 31 August 2024) at a weighted average price of €4.22 for a total consideration of €10,231,335. As at 31 August 2024 approximately 41% of the maximum total value of the share buyback programme has been completed.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. At 31 March 2024, the Bank of Cyprus Group operated through a total of 58 branches in Cyprus, of which 3 operated as cash offices. The Bank of Cyprus Group employed 2,847 staff worldwide. At 31 March 2024, the Group's Total Assets amounted to €24.9 bn and Total Equity was €2.6 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAKNAEAKLEEA
Date   Source Headline
24th Aug 202211:27 amRNSForm 8.3 - Bank of Cyprus Holdings plc
24th Aug 202210:45 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Bank of Cyprus Holdings plc
24th Aug 20229:18 amRNSForm 38.5 (EPT/RI)
24th Aug 20227:00 amRNSForm 8.3 - Bank of Cyprus Holdings PLC
23rd Aug 20222:43 pmRNSForm 8.3 - Bank of Cyprus Holdings plc
23rd Aug 202212:47 pmGNWHSBC Bank Plc - FORM 38.5(a) (EPT/RI) - Bank of Cyprus Holdings plc
23rd Aug 202211:40 amRNSForm 38.5a - Bank of Cyprus Holdings Plc
23rd Aug 20228:47 amRNSForm 38.5 (EPT/RI)
22nd Aug 20222:32 pmRNSForm 8.3 - Bank of Cyprus Holdings plc
22nd Aug 202211:29 amRNSForm 38.5 (EPT/RI)
22nd Aug 202210:03 amRNSAnnouncement of Publication of Docs. on Website
22nd Aug 20227:00 amRNSRelevant Securities in Issue
19th Aug 20226:18 pmRNSResponse to statement by LSF XI Investments LLC
19th Aug 20223:56 pmRNSStatement re Possible Offer
9th Aug 20221:26 pmRNSAmendment to Covered Bond Terms and Conditions
9th Aug 20227:04 amRNSDate of announcement of 1H2022 FR
25th Jul 20227:08 amRNSCompletion of Voluntary Staff Exit Plan
6th Jun 20227:00 amRNSTR1 Notification- Senvest
26th May 20227:00 amRNSTR1 Notification - Eaton Vance
23rd May 202210:35 amRNSBoard and Board Committees Composition
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.